Trial intelligence / Profile preview

Phase III trial of oral AND017 for anemia in dialysis-dependent chronic kidney disease

CTR20253615Phase 3Active

Sponsor
Ando Pharma
Start
Oct 2025
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of AND017 in anaemia, sponsored by Ando Pharma. Started Oct 2025; status: active.

02

Drugs

AND017
03

Conditions

anaemia

Beyond the preview

Go deeper on CTR20253615.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20253615.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call